Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand – Genetic Engineering News

May 29, 2012 Posted By: Leave a comment
This particular patent - the first on our oral exenatide formulation - allows Oramed to gain yet more ground in the biotechnology world ... Except as otherwise required by law, Oramed undertakes no obligation to publicly release any revisions ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>